Curia, formerly AMRI, is a leading contract research, development and manufacturing organization providing products and services from R&D through commercial manufacturing of large and small molecules to pharmaceutical and biopharmaceutical customers. Curia's 3,700 employees at 30 locations across the U.S., Europe and Asia help its customers advance from curiosity to cure. Learn more at

Research & Development

Discovery:​ Identify, refine and secure breakthrough compounds. Curia is an extension of your team, applying deep scientific expertise to help you accelerate progress and meet critical milestones.

Drug Substance & Process Development:​ Advance the development of your compound. Leverage our unmatched experience and flexibility to navigate toward product launch.

Drug Product Formulation & Process Development:​ Maximize the potential of your formulation. Trust our practical experience, rigorous quality standards, and risk assessment expertise to guide the development of your injectable product.

Commercial Manufacturing

Drug Substance Manufacturing:​ Securely move your complex compound from development to commercial manufacture. Our scale-up and tech transfer expertise brings your product to market quickly and safely.

Drug Product Manufacturing:​ Maximize the impact of your product. Curia delivers high-quality, flexible sterile contract manufacturing services customized to meet your needs.

Related resources

Flexibility and capability in pre-filled syringes

Flexibility and capability in pre-filled syringes

Curia | 15-Nov-2021 | Technical / White Paper

Pre-filled syringes have risen in popularity in recent years but the pandemic’s impact on drug development, manufacturing and patient care has created...